ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).
Recapping the Endpoints 100: The biotech industry braces itself for Trump 2.0
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS